PHARMANETUSA

PharmaNetUSA Inc. with breakthrough innovations in drug testing and specialized Medical Clinics, is poised to capture significant new business in pain management. Pain is the most common reason for seeking medical care with 32.8% of the population having persistent or chronic pain symptoms. Everyday 46 people die from an overdose of prescription painkillers in the U.S.. Most Physicians receive little or no training to treat pain, and less on how to identify abusers. Clearly there is a marke... t void in pain management. PharmaNetUSA Inc. is launching a new business to fill this market void and provide significant returns to its investors. To capture this market, PharmaNetUSA Inc. is opening a series of Chronic Pain Management Clinics and Drug Testing Labs in the USA. Based on market forecasts, we will capture sales of over $7.26 million in our first year of operations with EBITDA of over $3.178 million, and $22.3 million in our second year of operations with an EBITDA of $13.76 million. An indication of our potential for growth is large margins between our cost and sell price. Reimbursement rates for Urine Drug Testing from Medicaid/Medicare is $300 per test, and our all-inclusive cost is $75 per test. (75% margin or 300% markup) PharmaNetUSA will begin operations in nine States that have passed “Pain Management Clinic Acts’ mandating that patients who have been prescribed narcotic medication for chronic and acute conditions, must participate in mandatory urine drug testing on a routine basis for compliance and for detection of potential abuses and illicit drugs. PharmaNetUSA is uniquely positioned to rapidly become a leader in TeleHealth Chronic Pain Management Programs through our specialized Medical Clinics and State of the Art Drug Testing Laboratory. Our TeleHealth Network has the capability to link any Community, Agency, Physician, Treatment Provider or Patient with one of our Specialist Clinics, thus greatly streamlining the process and reducing costs.More